PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 10, 2017Clinical and Molecular HepatologyOpen Access

NASH Therapy: omega 3 supplementation, vitamin E, insulin sensitizers and statin drugs

View Full Paper
Ask AI
Bookmark
Share

Population

Patients with Non-alcoholic steatohepatitis (NASH), including pediatric and adult populations

Design

Review

Authors

SCStephen H. Caldwell

Discussion

Loading...

Member takes

Overview

Statins should be prescribed for cardiovascular risk reduction rather than NASH treatment; leaves.

Structured PICO

P
Population
Patients with Non-alcoholic steatohepatitis (NASH), including pediatric and adult populations
I
Intervention
Polyunsaturated Fatty Acid (PUFA) supplements, vitamin E, insulin sensitizing agents (pioglitazone, liraglutide), and statins
O
Outcome
Liver fat reduction and histological benefit

Older therapies for NASH have variable efficacy, with statins showing neutral effects on liver histology and their use best guided by cardiovascular risk.

Cite This Study

Stephen H. Caldwell (2017) studied this question.

synapsesocial.com/papers/6a7eb72492a53ed74d8ba051https://doi.org/10.3350/cmh.2017.0103
View Full Paper
Ask AI
Bookmark
Share